Welcome to our dedicated page for Oaktree Specialty SEC filings (Ticker: OCSL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Oaktree Specialty Lending Corporation (OCSL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Nasdaq-listed business development company. These filings offer detailed information on its specialty finance activities, portfolio performance, capital structure, and governance.
Investors can review Form 8-K current reports in which Oaktree Specialty Lending discloses material events. Recent 8-K filings have covered quarterly and annual financial results, including total investment income, net investment income, adjusted non-GAAP metrics, and net asset value per share, as well as the availability of related earnings presentations. Other 8-K filings have reported corporate actions such as the election of a Chief Operating Officer.
Through its periodic reports, OCSL describes its status as a business development company under the Investment Company Act of 1940, its listing of common stock on The Nasdaq Stock Market LLC under the symbol OCSL, and details about its investment portfolio. These documents include disclosures on first and second lien loans, unsecured and mezzanine loans, preferred equity, joint venture interests, non-accrual investments, and the mix of floating-rate and fixed-rate instruments.
Filings also discuss capital markets and financing activities, such as amendments to its senior secured revolving credit facility, the extension of its final maturity, changes to SOFR-based pricing, and the issuance and repayment of unsecured notes. Information on management and incentive fee arrangements, fee waivers, and total return hurdles is likewise contained in SEC reports.
On Stock Titan, these filings are updated from EDGAR in near real time and paired with AI-powered summaries that highlight key points from lengthy documents. Users can quickly understand the implications of new 8-Ks, annual and quarterly reports, and other SEC submissions, and can use the filings page as a central reference for OCSL’s regulatory and financial history.
Oaktree Specialty Lending Corporation reported results from its 2026 annual meeting of stockholders. Stockholders elected John B. Frank (33,749,567 votes for, 2,303,930 withheld) and Bruce Zimmerman (33,868,064 votes for, 2,185,433 withheld) to serve as directors until the 2029 annual meeting, with 23,312,367 broker non-votes for each nominee.
Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 58,021,388 votes for, 842,271 against, and 502,205 abstentions. A separate special meeting to consider authorizing common stock issuances below net asset value, up to 25% of then-outstanding shares, was adjourned due to lack of a quorum.
Oaktree Specialty Lending Corporation furnished an update on its latest financial results. The company issued a press release announcing results for the fiscal quarter ended December 31, 2025, and made an accompanying earnings presentation available on its website.
The press release is included as Exhibit 99.1 and the first quarter 2026 earnings presentation as Exhibit 99.2. The company also scheduled a conference call on February 4, 2026 to discuss these quarterly results. The information in this report and the exhibits is being furnished rather than filed under securities laws.
Oaktree Specialty Lending Corporation is holding its 2026 virtual annual stockholder meeting on March 3, 2026. Stockholders of record as of January 5, 2026, when 88,085,523 common shares were outstanding, may vote online or by phone.
Investors will vote on two items: electing directors John B. Frank (interested director and board chair) and Bruce Zimmerman (lead independent director) to terms running to the 2029 annual meeting, and ratifying Ernst & Young LLP as independent auditor for the fiscal year ending September 30, 2026. The board recommends voting “FOR” both proposals.
The filing details governance practices, director independence and compensation, and related-party arrangements. The external adviser, an Oaktree affiliate, earns a 1.00% base management fee on gross assets (excluding cash) and 17.5% performance-based incentive fees, while an Oaktree affiliate administrator received about $2.4 million of reimbursed expenses in fiscal 2025. Audit and tax fees paid to EY were about $1.37 million and $0.45 million, respectively, in fiscal 2025. Brookfield has agreed to acquire the remaining 26% interest in Oaktree and its affiliates, which would give it full ownership after the expected first-quarter 2026 closing.
Oaktree Specialty Lending Corporation has called a virtual 2026 Special Meeting on March 3, 2026 to ask stockholders to approve a single proposal. The proposal would authorize the company, with Board approval, to sell or otherwise issue common stock at prices below its then-current net asset value (NAV) per share, as long as the number of new shares does not exceed 25% of the then-outstanding common stock and the authorization lasts for twelve months.
As of January 2, 2026, the company had 88,085,523 shares outstanding, and its shares have recently traded at a discount to NAV; for example, on January 5, 2026 the Nasdaq price of $12.91 was about 22.4% below NAV per share as of September 30, 2025. The Board, including all independent directors, argues that below-NAV issuance authority could give the BDC flexibility to raise equity during periods of market volatility, support compliance with asset coverage and debt covenants, and pursue attractive investments or acquisitions.
The proxy statement explains in detail how issuing stock below NAV can dilute existing holders’ NAV per share, ownership percentage and voting power, and provides numerical examples of dilution and accretion under different discount and participation scenarios. Stockholders will have no preemptive rights in any such issuance, and the Board emphasizes that the total shares issuable below NAV would be capped at 25% of outstanding shares. The Board unanimously recommends voting “FOR” the proposal.
Oaktree Specialty Lending Corporation reported that it has released its financial results for the fiscal quarter and year ended September 30, 2025, through a press release furnished as Exhibit 99.1. The company is also hosting a conference call on November 18, 2025, to discuss these results and has made an accompanying fourth quarter and fiscal year 2025 earnings investor presentation available on its website, furnished as Exhibit 99.2.
Oaktree Specialty Lending Corporation files its annual report describing a specialty finance business focused on customized credit to middle‑market companies. The company operates as a closed‑end Business Development Company and a regulated investment company, externally managed by Oaktree Fund Advisors.
As of September 30, 2025, its investment portfolio totaled $2.8 billion at fair value across 143 portfolio companies, with 94.6% in debt investments and 85.9% in senior secured loans. The weighted average annual yield was 9.8% on debt investments and 9.4% on total investments.
Oaktree Specialty Lending targets a long‑term debt‑to‑equity ratio of 0.90x to 1.25x and reported net debt to equity of 0.97x as of September 30, 2025. The company also highlights joint venture exposures through Senior Loan Fund JV I and OCSI Glick JV, and notes 88,085,523 common shares outstanding as of November 14, 2025.
Oaktree Specialty Lending Corporation appointed Brett McKeone as Chief Operating Officer, effective December 31, 2025. McKeone, 48, is a managing director within Oaktree’s Global Private Debt strategy and has been with Oaktree since 2007. His prior experience includes roles at Deloitte Consulting’s Strategy and Operations practice and Exxon Mobil. He holds M.S. and B.S. degrees in mechanical engineering from MIT, an M.B.A. from UCLA Anderson, and is a CFA charterholder. The company states he has no family relationships with current directors or executive officers and no transactions requiring disclosure under Item 404(a).
Phyllis R. Caldwell, a director of Oaktree Specialty Lending Corp (OCSL), reported purchases on 09/15/2025 totaling 3,000 shares of common stock at prices ranging from $13.1884 to $13.1999. After these transactions she beneficially owned 21,000 shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025.